Compare REFR & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REFR | ICCM |
|---|---|---|
| Founded | 1965 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8M | 45.5M |
| IPO Year | N/A | N/A |
| Metric | REFR | ICCM |
|---|---|---|
| Price | $1.62 | $0.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 60.0K | ★ 403.0K |
| Earning Date | 11-06-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,227,276.00 | ★ $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $0.59 |
| 52 Week High | $2.70 | $1.66 |
| Indicator | REFR | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 44.04 | 41.99 |
| Support Level | $1.85 | $0.67 |
| Resistance Level | $2.10 | $0.72 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 17.24 | 62.50 |
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.